Property Summary

NCBI Gene PubMed Count 38
PubMed Score 14.90
PubTator Score 25.97

Knowledge Summary


No data available


  Disease Sources (3)

Disease Target Count
HIV Infections 100
Disease Target Count P-value
lung adenocarcinoma 2714 6.08664065499481E-8
atypical teratoid/rhabdoid tumor 1095 8.03279824814654E-7
Multiple myeloma 1328 1.14356392668223E-5
sonic hedgehog group medulloblastoma 1482 8.3521920499585E-5
lung cancer 4473 1.68486233340084E-4
ovarian cancer 8492 5.49741534404977E-4
Waldenstrons macroglobulinemia 765 7.62277088202241E-4
diabetes mellitus 1663 0.00179849416317573
non primary Sjogren syndrome sicca 840 0.0418415721876797
Disease Target Count Z-score Confidence
Autosomal dominant cerebellar ataxia 34 3.008 1.5


  Differential Expression (9)


Accession Q13242 Q52LD1
Symbols SFRS9


  Ortholog (10)

 GO Component (2)

Gene RIF (14)

25665148 Report no correlation between expression of glucocorticoid receptor isoforms and SRp30c.
23592547 Overexpression of SRSF9 and SRSF1 promote beta-catenin accumulation via the recruitment of beta-catenin mRNA and by enhancing its translation in an mTOR-dependent manner.
22205602 Relative levels of SRp20, SRp30c, and SRp40 in TM cells control differential expression of the two alternatively spliced isoforms of the GR and thereby regulate GC responsiveness.
22178073 these data indicated that tumor suppressive miR-1 induces apoptosis through direct inhibition of SRSF9 in bladder cancer.
22174317 HIV-1 Rev interacting protein, serine/arginine-rich splicing factor 9 (SRSF9), is identified by the in-vitro binding experiments involving cytosolic or nuclear extracts from HeLa cells. The interaction of Rev with SRSF9 is increased by RRE
21697349 These results suggest that SRp30c can activate human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism: directly by stimulating splicing to late splice sites and indirectly by inhibiting competing early splice sites.
20376328 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
19557313 findings indicate the importance of arginine methylation for the subnuclear localization of SFRS9.
18534987 SRp30c stimulates splicing to the downstream 5' splice site of Bcl-x(L), thereby attenuating the repressive effect of upstream U1 snRNP binding sit
17548433 Study shows that PTB can function as an anti-repressor molecule to counteract the splicing inhibitory activity of SRp30c.

AA Sequence

SPHYFSPFRPY                                                               211 - 221

Text Mined References (47)

PMID Year Title
25944712 2015 N-terminome analysis of the human mitochondrial proteome.
25665148 Expression of glucocorticoid receptor isoforms and associations with serine/arginine-rich protein 30c and 40 in patients with systemic lupus erythematosus.
24275569 2014 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
23592547 2013 SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing ?-catenin biosynthesis.
23186163 2013 Toward a comprehensive characterization of a human cancer cell phosphoproteome.
22681889 2012 The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.
22658674 2012 Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.
22205602 2012 Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells.
22178073 2012 Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
21697349 2011 Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism.